Study S001211

A Randomised, Double-blind, Placebo-controlled Study of the Effect of LIraglutide on Left VEntricular Function in Chronic Heart Failure Patients With and Without Type 2 Diabetes (The LIVE-study)

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT01472640
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: QUADRUPLE
Status: COMPLETED
Enrollment: 240
Start: 2011-11
Primary completion: 2015-09
Lead sponsor: Flyvbjerg, Allan, DMSc
Conditions: Hyperglycemia; Chronic Heart Failure
Interventions: DRUG:liraglutide; DRUG:placebo
Results posted: FALSE
Secondary identifiers: EUDRACT_NUMBER:2011-002468-26

Registered primary outcomes

Change in Left ventricular function from visit 1 to week 24, measured by Ecco [24 weeks]

Linked records (2)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0021443	Effect of liraglutide on myocardial glucose uptake and blood flow in stable chronic heart failure patients: A double-blind, randomized, placebo-controlled LIVE sub-study. Nielsen R, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology	2019	Randomized trial	PMID 28770459 DOI	cites ClinicalTrials.gov:NCT01472640; registry reference DERIVED:28770459
R0022195	A protocol for a randomised, double-blind, placebo-controlled study of the effect of LIraglutide on left VEntricular function in chronic heart failure patients with and without type 2 diabetes (The LIVE Study). Jorsal A, BMJ open	2014	Protocol	PMID 24844271 DOI	cites ClinicalTrials.gov:NCT01472640; registry reference DERIVED:24844271